Iran receives China s Sinopharm jabs as COVID deaths reach 60,000 | Coronavirus pandemic News aljazeera.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aljazeera.com Daily Mail and Mail on Sunday newspapers.
Sunday, 07 February 2021 3:09 PM
[ Last Update: Sunday, 07 February 2021 3:19 PM ] A health worker holds a vial of Russia’s Sputnik V COVID-19 vaccine in Belgrade Fair turned into a vaccination center, February 4, 2021. (Photo by AFP)
A delegation from Iran’s Health Ministry headed by a deputy health minister has arrived in Moscow to discuss cooperation between the two sides in a variety of health-related areas, particularly the co-production of Russia’s coronavirus vaccine.
The team is set to hold talks with Russian officials, including the health minister, on the co-production of Sputnik-V vaccine, and expects to sign an agreement with the Gamaleya Research Institute of Epidemiology and Microbiology, which develops the vaccine.
Sunday, 07 February 2021 11:11 AM
[ Last Update: Sunday, 07 February 2021 11:39 AM ] COV-Pars vaccines produced by Iran’s Razi Vaccine and Serum Research Institute against the COVID-19 are unveiled at a ceremony in Tehran on February 7, 2021. (Photo by IRNA news agency)
Iran has launched the first phase in the human trial of its second COVID-19 vaccine developed by the Razi Vaccine and Serum Research Institute.
The vaccine, Razi COV-Pars, was unveiled during a ceremony in Tehran on Sunday, with Health Minister Saeed Namaki, Agriculture Minister Kazem Khavazi and Vice President for Science and Technology Sourena Sattari in attendance.
Razi COV-Pars, administered via injection and inhalation, is an mRNA recombinant vaccine that reconstructs a harmless piece of the virus’ spike protein.